MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS
Abstract. We investigated the ability of autologous/allogeneic mesenchymal stem cells (MSC) from early passages, derived from bone marrow of patients with multiple sclerosis, to inhibit mitogen/myelin-induced proliferation of memory T cells. It was shown that MSC immunosuppressive potenti...
Enregistré dans:
Auteurs principaux: | M. M. Zafranskaya, D. B. Nizhegorodova, M. Yu. Yurkevich, S. S. Bagatka, H. I. Ivanchyk, Yana M. Motuzova, A. S. Fedulov |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7f19bed10f4d40aa8b8a8c89bdb016b4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
par: Michelle Broekhuizen, et autres
Publié: (2021) -
Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase
par: Raghavan Chinnadurai, et autres
Publié: (2021) -
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
par: Rivera,Francisco J, et autres
Publié: (2012) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
par: Corina Bello, et autres
Publié: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
par: V. A. Kozlov, et autres
Publié: (2017)